September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
In vivo reprogramming of rods to cone-like cells by Nrl-knockdown using AAV-delivered CRISPR-Cas9 rescues retinal degeneration
Author Affiliations & Notes
  • Wenhan Yu
    Ocular Gene Therapy Core, National Eye Institute/NIH., Bethesda, Maryland, United States
  • Suddhasil Mookherjee
    Ocular Gene Therapy Core, National Eye Institute/NIH., Bethesda, Maryland, United States
  • Jung-Woong Kim
    Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute, NIH, Bethesda, Maryland, United States
  • Suja Hiriyanna
    Ocular Gene Therapy Core, National Eye Institute/NIH., Bethesda, Maryland, United States
  • Yasaman Ataeijannati
    Ocular Gene Therapy Core, National Eye Institute/NIH., Bethesda, Maryland, United States
  • Xun Sun
    Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute, NIH, Bethesda, Maryland, United States
  • Lijin Dong
    Genetic Engineering Core, National Eye Institute, NIH, Bethesda, Maryland, United States
  • Tiansen Li
    Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute, NIH, Bethesda, Maryland, United States
  • Anand Swaroop
    Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute, NIH, Bethesda, Maryland, United States
  • Zhijian Wu
    Ocular Gene Therapy Core, National Eye Institute/NIH., Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Wenhan Yu, None; Suddhasil Mookherjee, None; Jung-Woong Kim, None; Suja Hiriyanna, None; Yasaman Ataeijannati, None; Xun Sun, None; Lijin Dong, None; Tiansen Li, None; Anand Swaroop, None; Zhijian Wu, None
  • Footnotes
    Support  This work was supported by the intramural research program of the National Eye Institute
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wenhan Yu, Suddhasil Mookherjee, Jung-Woong Kim, Suja Hiriyanna, Yasaman Ataeijannati, Xun Sun, Lijin Dong, Tiansen Li, Anand Swaroop, Zhijian Wu; In vivo reprogramming of rods to cone-like cells by Nrl-knockdown using AAV-delivered CRISPR-Cas9 rescues retinal degeneration. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis pigmentosa (RP) is the most common form of inherited retinal dystrophy, characterized by an initial loss of rod photoreceptors and secondary cone death. Acute gene knockout of rod determinant Nrl was shown to reprogram adult rods into cone-like cells, rendering them resistant to effects of mutations in rod-specific genes and consequently preventing secondary cone loss (Montana CL, et al. PNAS, 2013; 110: 1732-7). With a goal to develop this approach for treatment of RP, we used adeno-associated virus (AAV)-delivered CRISPR/Cas9 for Nrl-knockdown in rods.

Methods : Two AAV vectors were constructed for CRISPR/Cas9 knockdown strategy, one expressing Cas9 nuclease, and the other carrying a single-guided RNA targeting the Nrl gene. The two vectors were co-delivered into mice by subretinal administration. Potency of the system was validated by EGFP knockdown in a mouse line with eGFP-labeled rods. Nrl knockdown was conducted in wild-type C57/Bl6 or Crxp-Nrl, a mouse line with rod-only photoreceptors. Molecular, histological and functional alterations were examined by next generation sequencing, immunoblot analysis, immunofluorescence and electron microscopy, and electroretinography (ERG). Rescue of retinal degeneration was assessed in three mouse models harboring either recessive or dominant rod-specific mutations.

Results : eGFP and Nrl were efficiently knocked down following AAV-CRISPR/Cas9 treatment. For Nrl knockdown, insertions and deletions were only detected in the targeted Nrl locus, and no mutation was identified in ten potential off-target loci. A majority of the transduced rods acquired characteristics of cone photoreceptors, as demonstrated by reduced expression of rod-specific genes and enhanced expression of cone-specific genes, loss of the unique rod chromatin pattern, and diminished rod ERG response. In all three disease models, the Nrl-CRISPR/Cas9 treated eyes maintained significantly better photoreceptor viability and cone function than control eyes, as revealed by remarkably thicker photoreceptor layer, higher cone cell number, greater cone ERG amplitude and better optomotor behavior.

Conclusions : AAV-CRISPR/Cas9-mediated Nrl knockdown can efficiently reprogram rods into cone-like photoreceptors and prevent secondary cone death in retinal degeneration. We believe NRL-knockdown can be developed into a viable treatment for RP in humans.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×